This brand name is authorized in United States
The drug NOURIANZ contains one active pharmaceutical ingredient (API):
|
1
Istradefylline
UNII 2GZ0LIK7T4 - ISTRADEFYLLINE
|
|
Istradefylline is an adenosine receptor antagonist. The precise mechanism by which istradefylline exerts its therapeutic effect in Parkinson disease is unknown. In in vitro studies and in in vivo animal studies, istradefylline was demonstrated to be an adenosine A2A receptor antagonist. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| NOURIANZ Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 42747-602, 42747-604 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
